Treatment of mitochondrial cytopathies
- PMID: 11641821
- DOI: 10.1055/s-2001-17948
Treatment of mitochondrial cytopathies
Abstract
Mitochondrial cytopathies are clinically and biochemically heterogeneous disorders affecting energy production. Because of the diverse symptoms spanning organ systems, the large number of biochemical and genetic defects, and an unpredictable clinical course, there are limited data regarding proven effective therapies. In general, treatments for mitochondrial cytopathies are intended to augment energy production as well as reduce the production of free radicals and other toxic metabolites that further limit the generation of cellular energy. Theoretically, treatment can be aimed at increasing respiratory chain activity by supplementing relative deficiencies of cofactors required for proper functioning. Possible strategies to consider may include dietary management, supplemental vitamins and cofactors, and/or specific medications aimed at a particular symptom.
Similar articles
-
The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies.Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1561-7. doi: 10.1016/j.addr.2008.05.001. Epub 2008 Jul 4. Adv Drug Deliv Rev. 2008. PMID: 18647623 Review.
-
[Mitochondrial diseases].Rev Prat. 1993 Apr 1;43(7):868-74. Rev Prat. 1993. PMID: 8346403 Review. French.
-
[Mitochondrial encephalomyopathies starting in childhood and adolescence].Rev Neurol. 1998 Apr;26 Suppl 1:S61-71. Rev Neurol. 1998. PMID: 9810592 Review. Spanish.
-
[Ubiquinone: metabolism and functions. Ubiquinone deficiency and its implication in mitochondrial encephalopathies. Treatment with ubiquinone].Rev Neurol. 1999 Jul 1-15;29(1):59-63. Rev Neurol. 1999. PMID: 10528314 Review. Spanish.
-
Treatment of mitochondrial encephalomyopathies with a xanthine oxidase inhibitor.Pediatr Neurol. 2006 Nov;35(5):318-22. doi: 10.1016/j.pediatrneurol.2006.05.012. Pediatr Neurol. 2006. PMID: 17074601
Cited by
-
The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.CNS Drugs. 2006;20(6):443-64. doi: 10.2165/00023210-200620060-00002. CNS Drugs. 2006. PMID: 16734497 Review.
-
Pulmonary hypertension as a manifestation of mitochondrial disease: A case report and review of the literature.Medicine (Baltimore). 2017 Nov;96(46):e8716. doi: 10.1097/MD.0000000000008716. Medicine (Baltimore). 2017. PMID: 29145311 Free PMC article. Review.
-
Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.Neurotherapeutics. 2013 Apr;10(2):186-98. doi: 10.1007/s13311-013-0177-6. Neurotherapeutics. 2013. PMID: 23385875 Free PMC article. Review.
-
Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.Br J Pharmacol. 2012 Nov;167(6):1311-28. doi: 10.1111/j.1476-5381.2012.02086.x. Br J Pharmacol. 2012. PMID: 22747838 Free PMC article.
-
Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.PLoS One. 2010 Jan 25;5(1):e8872. doi: 10.1371/journal.pone.0008872. PLoS One. 2010. PMID: 20111601 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
